Updated U.S. Guidelines for Antiretroviral Treatment of Children with HIV

alt

The U.S. Department of Health and Human Services has updated its Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. Reflecting recent data from the START and PENPACT1 trials, the guidelines now recommend that all children with HIV start antiretroviral therapy (ART) regardless of CD4 T-cell count, viral load, or clinical symptoms.

The latest revisions update theprior pediatric guidelines fromMarch 5, 2015. Comments on the new guidelines will be accepted through March 15, 2016, and can be sent to JLIB_HTML_CLOAKING .

Selected key changes include the following:

3/8/16

Reference

DHHS Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. Updated March 1, 2016.